CRNX - Court decision on ACA is a positive on the sector: Bernstein Prothena upgraded at BofA; in today's analyst action

yucelyilmaz/iStock via Getty Images Supreme Court decision on ACA is a positive for Centene  Managed care organizations such as Centene (CNC) and Molina (MOH) rose yesterday in response to the Supreme Court decision to uphold the Affordable Care Act. Bernstein analyst Lance Wikes sees the ruling as one of the strongest outcomes supporting the ACA. The decision could be positive for Centene and the sector in general, Wikes argues in a note to clients. Despite its recent underperformance relative to the broader market, Centene remains a favorite among Wall Street analysts and Seeking Alpha authors. Prothena upgraded at BofA citing experimental Alzheimer’s therapy Prothena (PRTA) is trading marginally higher in early hours after Bank of America upgraded the stock to neutral from underperform noting that the FDA’s accelerated approval for Biogen’s Alzheimer’s therapy Aduhelm “bodes positively for Prothena’s PRX012.” The price target increased to $49.00 from $12.00 per share indicates a premium

For further details see:

Court decision on ACA is a positive on the sector: Bernstein, Prothena upgraded at BofA; in today’s analyst action